Cerebrolysin
Cerebrolysin
A peptide mixture derived from porcine brain tissue with nootropic and neuroprotective properties. Used clinically in Europe for stroke, dementia, and TBI.
Typical Cost
$300-600/course
Status
Research
Peptide Profile
Cerebrolysin
Mechanism of Action
Contains low molecular weight peptides that cross BBB and provide neurotrophic support. Enhances neuronal survival, neurogenesis, and cognitive function through multiple mechanisms.
Common Dosages
intramuscular or intravenous
10-30mL
Daily or 5x weekly · 10-20 days
Benefits
Neuroprotection
Cognitive enhancement
Stroke recovery
TBI support
Dementia symptom management
Side Effects
Injection site reactions
Headache
Dizziness
Allergy to porcine products
Key Research
Cerebrolysin stroke recovery
Improved functional outcomes when started within 72 hours of stroke
Cerebrolysin Alzheimer's
Slowed cognitive decline in Alzheimer's patients
Regulatory Status
Approved in 44+ countries for neurological conditions. Not FDA-approved. Import for personal use.
Contraindications
- ⚠Allergy to porcine products
- ⚠Severe renal impairment
- ⚠Pregnancy/breastfeeding
GLP-1 users concerned about cognitive health may consider alongside SeraVia Energy+ Boost and Vitality+ Multi.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.